Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis
- PMID: 37223526
- PMCID: PMC10201558
- DOI: 10.1016/j.gendis.2021.12.007
Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis
Abstract
Atherosclerosis, the underlying pathophysiological basis of cardiovascular disease, has been recognized as a lipid-driven chronic inflammatory disease. Sterol carrier protein 2 (SCP-2) is a 13-kDa non-specific lipid-transfer protein expressed by various tissues and cells, such as liver, heart, vascular smooth muscle cells (VSMCs), and macrophages. SCP-2 has an extensive role in cardiovascular and metabolic diseases. Recently, SCP-2 was reported to promote the development of atherosclerosis by regulating lipid metabolism and peroxidation, endocannabinoid metabolism, vascular inflammation, and fatty acid metabolism. In this review, we summarized the recent advances regarding the role of SCP-2 in the pathogenesis of atherosclerosis and tried to provide a rationale for future investigation and a better understanding of the biological functions of SCP-2 in atherosclerotic cardiovascular disease.
Keywords: Atherosclerosis; Fatty acid metabolism; Lipid metabolism; SCP-2; Vascular inflammation.
© 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Figures


Similar articles
-
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications.Metabolism. 2022 Jun;131:155180. doi: 10.1016/j.metabol.2022.155180. Epub 2022 Mar 17. Metabolism. 2022. PMID: 35311663 Review.
-
Sterol carrier protein-2: not just for cholesterol any more.Mol Cell Biochem. 2002 Oct;239(1-2):87-93. Mol Cell Biochem. 2002. PMID: 12479573
-
Lipid specificity and location of the sterol carrier protein-2 fatty acid-binding site: a fluorescence displacement and energy transfer study.Lipids. 1997 Nov;32(11):1201-9. doi: 10.1007/s11745-997-0154-5. Lipids. 1997. PMID: 9397406
-
Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics.Biochemistry. 2001 May 29;40(21):6493-506. doi: 10.1021/bi010217l. Biochemistry. 2001. PMID: 11371213
-
Gene structure, intracellular localization, and functional roles of sterol carrier protein-2.Prog Lipid Res. 2001 Nov;40(6):498-563. doi: 10.1016/s0163-7827(01)00015-7. Prog Lipid Res. 2001. PMID: 11591437 Review.
Cited by
-
Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties.Pharmaceuticals (Basel). 2023 Jun 15;16(6):887. doi: 10.3390/ph16060887. Pharmaceuticals (Basel). 2023. PMID: 37375834 Free PMC article. Review.
-
Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.Sci Rep. 2024 May 14;14(1):10996. doi: 10.1038/s41598-024-61820-x. Sci Rep. 2024. PMID: 38744926 Free PMC article.
References
-
- Scannapieco F.A., Bush R.B., Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol. 2003;8(1):38–53. - PubMed
-
- Anand S.S., Yusuf S., Vuksan V., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet. 2000;356(9226):279–284. - PubMed
-
- Maguire E.M., Pearce S.W.A., Xiao Q. Foam cell formation: a new target for fighting atherosclerosis and cardiovascular disease. Vasc Pharmacol. 2019;112:54–71. - PubMed
Publication types
LinkOut - more resources
Full Text Sources